NexEos Diagnostics, Inc. is a privately held medical diagnostics company structtured around mproving the diagnosis, life-long management and treatment of patients living with chronic, eosinophil-related inflammatory diseases. Through the licensing, development, and commercialization of novel technologies, NexEos Diagnostics, Inc. is bringing new tools to market that address the (currently) unmet needs of patients suffering from eosinophil-related diseases. The firm's lead program is a novel, rapid imaging agent for the diagnosis, treatment monitoring, and management of eosinophilic esophagitis (EoE) to allow patients to maintain a quality life and halt their disease progression.
